Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Raw Materials (2019 - 2025)

Pulmonx has reported Raw Materials over the past 7 years, most recently at $4.9 million for Q4 2025.

  • Quarterly Raw Materials rose 43.04% to $4.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2025, up 43.04% year-over-year, with the annual reading at $4.9 million for FY2025, 43.04% up from the prior year.
  • Raw Materials was $4.9 million for Q4 2025 at Pulmonx, up from $4.3 million in the prior quarter.
  • Over five years, Raw Materials peaked at $4.9 million in Q4 2025 and troughed at $2.9 million in Q3 2023.
  • The 5-year median for Raw Materials is $3.4 million (2023), against an average of $3.5 million.
  • Year-over-year, Raw Materials fell 23.46% in 2023 and then skyrocketed 43.04% in 2025.
  • A 5-year view of Raw Materials shows it stood at $3.7 million in 2021, then rose by 2.19% to $3.8 million in 2022, then fell by 23.46% to $2.9 million in 2023, then rose by 16.48% to $3.4 million in 2024, then skyrocketed by 43.04% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Raw Materials are $4.9 million (Q4 2025), $4.3 million (Q3 2025), and $3.9 million (Q2 2025).